The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
Glypican-1 (GPC-1) and other glypicans are a family of heparan sulfate proteoglycans. These proteins are highly expressed on the cell membrane and in the extracellular matrix, functioning mainly as modulators of growth factor signaling. Some of them are abnormally expressed in cancer, possibly invol...
Main Authors: | Sen Wang, Yudong Qiu, Bing Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00614/full |
Similar Items
-
Glypican-1 Overexpression in Different Types of Breast Cancers
by: Alshammari FO, et al.
Published: (2021-07-01) -
Editorial: Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
by: Cinzia Lanzi, et al.
Published: (2020-02-01) -
Glypicans and Heparan Sulfate in Synaptic Development, Neural Plasticity, and Neurological Disorders
by: Keisuke Kamimura, et al.
Published: (2021-02-01) -
Exploiting Heparan Sulfate Proteoglycans in Human Neurogenesis—Controlling Lineage Specification and Fate
by: Chieh Yu, et al.
Published: (2017-10-01) -
Heparan Sulfate Proteoglycans and Their Endogenous Modifying Enzymes: Cancer Players, Biomarkers and Therapeutic Targets
Published: (2020)